User profiles for Hugo de Jong

HWAM (Hugo) de Jong

Professor of Medical Physics, UMC Utrecht , the Netherlands, Dept. of Radiology
Verified email at umcutrecht.nl
Cited by 6246

90Y hepatic radioembolization: an update on current practice and recent developments

…, JF Prince, HWAM de Jong… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Radioembolization is an established treatment modality that has been subjected to many
improvements over the last decade. Developments are occurring at a high pace, affecting …

[HTML][HTML] The physics of radioembolization

…, B Kunnen, AJAT Braat, MGEH Lam, HWAM de Jong - EJNMMI physics, 2018 - Springer
Radioembolization is an established treatment for chemoresistant and unresectable liver
cancers. Currently, treatment planning is often based on semi-empirical methods, which yield …

[HTML][HTML] Holmium-166 radioembolization: current status and future prospective

…, AJAT Braat, R van Rooij, HWAM de Jong… - CardioVascular and …, 2022 - Springer
Since its first suggestion as possible option for liver radioembolization treatment, the
therapeutic isotope holmium-166 ( 166 Ho) caught the experts’ attention due to its imaging …

Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner

HWAM De Jong, FHP Van Velden… - Physics in Medicine …, 2007 - iopscience.iop.org
The ECAT high resolution research tomograph (HRRT) is a dedicated brain and small animal
PET scanner, with design features that enable high image spatial resolution combined …

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission …

…, RW van der Meer, HJ Lamb, HWAM de Jong… - Journal of the American …, 2009 - jacc.org
Objectives : This study was designed to evaluate myocardial substrate and high-energy
phosphate (HEP) metabolism in asymptomatic men with well-controlled, uncomplicated type 2 …

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate …

RW van der Meer, LJ Rijzewijk, HWAM de Jong… - Circulation, 2009 - Am Heart Assoc
Background— Cardiac disease is the leading cause of mortality in type 2 diabetes mellitus (T2DM).
Pioglitazone has been associated with improved cardiac outcome but also with an …

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization

…, MLJ Smits, M Elschot, HWAM de Jong… - Journal of Nuclear …, 2013 - Soc Nuclear Med
In hepatic 90 Y radioembolization, pretreatment 99m Tc-macroaggregated albumin ( 99m Tc-MAA)
nuclear imaging is used for lung shunt analysis, evaluation of extrahepatic deposition…

[HTML][HTML] Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization

…, B de Keizer, MAAJ van den Bosch, HWAM de Jong - PloS one, 2013 - journals.plos.org
Background After yttrium-90 ( 90 Y) microsphere radioembolization (RE), evaluation of
extrahepatic activity and liver dosimetry is typically performed on 90 Y Bremsstrahlung SPECT …

Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation

FJ Beekman, HWAM de Jong… - IEEE transactions on …, 2002 - ieeexplore.ieee.org
Quantitative accuracy of single photon emission computed tomography (SPECT) images is
highly dependent on the photon scatter model used for image reconstruction. Monte Carlo …

Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes

…, HW de Jong, JA Romijn, JJ Bax, A de Roos… - Journal of the American …, 2010 - jacc.org
Objectives : The purpose of this study was to investigate the relationship between hepatic
triglyceride content and both myocardial function and metabolism in type 2 diabetes mellitus (…